Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?

Expert Review of Neurotherapeutics

Volumn 11, Issue 9, 2011, Pages 1243-1246

  Amato, Maria Pia ^a   Portaccio, Emilio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

acetylcholinesterase inhibitors; cognitive impairment; donepezil; memory; multiple sclerosis

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

ARTICLE; ATTENTION; COGNITIVE DEFECT; EPISODIC MEMORY; EXECUTIVE FUNCTION; HUMAN; MEMORY DISORDER; MULTIPLE SCLEROSIS;

EID: 80052226401     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.105     Document Type: Article

References (16)

1. Compston A, Coles A. Multiple sclerosis. Lancet 372(9648), 1502-1517 (2008).
2. Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev. Neurother. 8(10), 1585-1596 (2008). .. Thorough review on cognitive impairment in multiple sclerosis.
3. Zipoli V, Goretti B, Hakiki B et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult. Scler. 16(1), 62-67 (2010).
4. Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 70(20), 1891-1897 (2008). (Pubitemid 351684642)
5. Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up. Neurology 75(13), 1134-1140 (2010).
6. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch. Neurol. 58(10), 1602-1606 (2001). (Pubitemid 32963224)
7. Amato MP, Portaccio E, Stromillo ML et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 71(9), 632-638 (2008).
8. Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63(9), 1579-1585 (2004). (Pubitemid 39507572)
9. Krupp LB, Christodoulou C, Melville P et al. Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 76(17), 1500-1507 (2011).
10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 33(11), 1444-1452 (2983).
11. Rao S. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Medical College of Wisconsin, WI, USA (1990).
12. Benedict RH, Fischer JS, Archibald CJ et al. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin. Neuropsychol. 16(3), 381-397 (2002). (Pubitemid 36390381)
13. Amato MP. Donepezil for memory impairment in multiple sclerosis. Lancet Neurol. 4(2), 72-73 (2005). (Pubitemid 40138921)
14. Sicotte NL, Kern KC, Giesser BS et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131(Pt 4), 1134-1141 (2008). . Study documenting hippocampal involvement in multiple sclerosis. (Pubitemid 351499428)
15. Filippi M, Rocca MA, Benedict RH et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75(23), 2121-2128 (2010). .. Comprehensive review on MRI correlates of cognitive impairment in multiple sclerosis.
16. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7(12), 1139-1151 (2008).